Georgia
Provider Communications
Anthem clinical criteria updates for specialty pharmacy are available
To access the clinical criteria document information please visit our provider website
Anthem’s prior authorization clinical review of non-oncology specialty pharmacy drugs will be managed by Anthem’s medical specialty drug review team. Drugs used for the treatment of Oncology will be managed by AIM Specialty Health® (AIM), a separate company
- ING-CC-0041 Complement Inhibitors
- ING-CC-0042 Monoclonal Antibodies to Interleukin-17
- ING-CC-0065 Agents for Hemophilia A and von Willebrand Disease
- ING-CC-0148 Agents for Hemophilia B
- ING-CC-0149 Select Clotting Agents for Bleeding Disorders
- ING-CC-0150 Kymriah (tisagenlecleucel)
Featured In:
February 2020 Anthem Provider News - Georgia